Expression of amphiregulin predicts poor outcome in patients with pancreatic ductal adenocarcinoma

BACKGROUND: The validation of novel diagnostic, prognostic and predictive biomarkers in cancer is crucial for optimizing the choice and efficacy of personalized therapies. The aim of this study was to determine the epidermal growth factor receptor (EGFR), epidermal growth factor receptor variant III...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Li, Wu, Huanwen, Wang, Lili, Lu, Junliang, Duan, Huanli, Liu, Xuguang, Liang, Zhiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938900/
https://www.ncbi.nlm.nih.gov/pubmed/27391842
http://dx.doi.org/10.1186/s13000-016-0512-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938900/
https://www.ncbi.nlm.nih.gov/pubmed/27391842
http://dx.doi.org/10.1186/s13000-016-0512-4

Ejemplares similares